Aurigene Discovery Technologies Limited clinical trials
A subsidiary of Dr. Reddy's Laboratories Limited
The registry lists 12 studies whose lead sponsor is Aurigene Discovery Technologies Limited. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 11, 2026.
Registry sponsor names on this page
- Aurigene Discovery Technologies Limited12 studies
Something wrong with this grouping? Tell us on the Dr. Reddy's Laboratories Limited page.
Studies
Recruiting first, then most recently updated. Showing 12 of 12. All Dr. Reddy's Laboratories Limited studies →
- AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)Not yet recruitingNCT07640737Phase 2
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)RecruitingNCT05865002Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)RecruitingNCT05984147Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced LymphomaRecruitingNCT06755450Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)TerminatedNCT06761586Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- First in Human, Dose Escalation, Dose Expansion Study of AUR105TerminatedNCT05605119Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal CancersTerminatedNCT06760702Phase 2
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and PharmacodynamicsTerminatedNCT05607199Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction AdenocarcinomaTerminatedNCT07040059Phase 1/2
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe PsoriasisCompletedNCT04207801Phase 2
Sponsor listed in the registry: Aurigene Discovery Technologies Limited
- A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)CompletedNCT04855721Phase 2
Sponsor listed in the registry: Aurigene Discovery Technologies Limited